The outcome of the lung cancer cohort study when confirmed in a larger cohort may support use of combined PET-MRI in monitoring ADC-detectable cell death and [18F]ICMT-11-detectable caspase-3/7 activation. The gene discussed is CASP3; the disease is lung cancer.